Notícias Eulerpool CStone Pharmaceuticals

CStone Pharmaceuticals Eulerpool-AFX

CStone Pharmaceuticals Notícias de ações

CStone Pharmaceuticals é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de CStone Pharmaceuticals nós reunimos aqui.

• 2 de setembro ·

  Yahoo
  High Growth Tech Stocks In Hong Kong Featuring SUNeVision Holdings And Two Others
• 23 de agosto ·

  Yahoo
  CStone Reports 2024 Interim Results and Recent Corporate Updates
• 26 de julho ·

  Yahoo
  CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer
• 2 de junho ·

  SeekingAlpha
  Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership
• 2 de junho ·

  Yahoo
  CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
• 26 de maio ·

  SeekingAlpha
  Week In Review: Hengrui And Dearon Announce $7.2B In Drug Licensings
• 24 de maio ·

  Yahoo
  CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website
• 27 de março ·

  Yahoo
  CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
• 15 de março ·

  Yahoo
  CStone Announces the Fifth Indication Approved for Sugemalimab in China as First-Line Treatment for Gastric Cancer
• 14 de março ·

  SeekingAlpha
  Stock Disconnect Triggers Investor Exodus From CStone Pharma